Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 75 /hr

★★★★★

☆☆☆☆☆

Hire Inderpreet S.

India

USD 75 /hr

HEOR Manager | Health Economics, Evidence Synthesis & Meta-Analysis Expert | SLR & Market Access Specialist

Profile Summary

Experienced Health Economics and Outcomes Research (HEOR) professional with 11+ years in pharmaceutical industry, specializing in evidence synthesis, meta-analysis, and systematic literature reviews. Led 100+ HEOR projects at Sanofi and Novartis, delivering strategic value communications and market access solutions for vaccines, rare disorders, ophthalmology, and biologics. Expert in health economic modeling (decision-tree, Markov, simulation), real-world evidence generation, HTA submissions, and cross-functional team management. Published extensively in peer-reviewed journals with focus on cost-effectiveness, patient preferences, and clinical outcomes research. Proficient in R, Python, and statistical analysis with strong background in epidemiology and patient engagement studies.

Subject Matter Expertise

• ☆ Statistics
• ☆ Meta-Analysis
• ☆ R
• ☆ Literature Review
• ☆ Systematic Literature Review
• ☆ Health Economics

Services

• Writing
• Research
• Consulting
• Data & AI

Writing Medical Writing, Technical Writing

Research Market Research, Meta-Research, Feasibility Study, Fact Checking, Gap Analysis, Gray Literature Search, Scientific and Technical Research, Systematic Literature Review, Secondary Data Collection

Consulting Scientific and Technical Consulting

Data & AI Predictive Modeling, Statistical Analysis, Image Analysis, Data Visualization, Data Cleaning, Data Processing

Work Experience

HEVA Manager

Sanofi (India)

July 2022 - March 2025

Value Access Manager

Novartis (India)

March 2020 - July 2022

Patient Access Services, Senior Analyst

Novartis (India)

January 2017 - February 2020

Associate

HERON-PAREXEL INTERNATIONAL

November 2014 - December 2016

Education

General Management

Indian schools of business

January 2025 - January 2025

Masters of Science

Cranfield University

June 2011 - June 2013

Bachelor in Pharmacy

Punjabi University Patiala - India

July 2006 - May 2010

B.Pharm

Punjabi University

2006 - 2010

Certifications

• Certification details not provided.

Publications

CONFERENCE PAPER

Inderpreet Singh Marwaha (2022). A UK Cost-minimization Analysis of Brolucizumab Versus Aflibercept in Diabetic Macular Oedema (DMO). ISPOR Europe 2022.

Inderpreet Singh Marwaha (2021). Cost-Comparison Model of Brolucizumab for Age-Related Macular Degeneration. ISPOR Europe 2021.

Inderpreet Singh Marwaha (2021). Linking WET Age-Related Macular Degeneration Real-World Evidence to Healthcare System Capacity and Spending. ISPOR Europe 2021.

Inderpreet Singh Marwaha (2021). Patient preferences in the management of wet AMD: a conjoint analysis. ISPOR Europe 2021.

Inderpreet Singh Marwaha (2021). Real world validation of healthcare capacity optimization measures guided by the SimPLI tool. ISPOR Europe 2021.

Inderpreet Singh Marwaha (2019). Epidemiology of proliferative diabetic retinopathy (PDR): evidence from literature review. ISPOR 2019.

Inderpreet Singh Marwaha (2018). Comparing long-term impact on healthcare resources and costs due to single-piece acrylic intraocular lens (IOLs) in cataract surgery: cost-consequence analysis. ISPOR-EU 2018.

Inderpreet Singh Marwaha (2018). Identifying patient preferences for glaucoma treatment: Evidence from literature review. ISPOR 2018.

Inderpreet Singh Marwaha (2018). Leveraging social media to explore patient experiences in neovascular AMD. ISPOR 2018.

Inderpreet Singh Marwaha (2016). HRQOL and health utility in newly diagnosed multiple myeloma (US & Europe): SLR. ISPOR 2016.

Inderpreet Singh Marwaha (2016). Literature review of studies assessing direct costs associated with migraine. AMCP 2016.

Inderpreet Singh Marwaha (2015). Systematic literature review of utility values in patients with migraine. ISPOR 2015.

JOURNAL ARTICLE

Inderpreet Singh Marwaha Comparative Efficacy of Anti-Vascular Endothelial Growth Factor (anti-VEGF) Agents for Treatment of Diabetic Macular Edema (DME): A Systematic Review and Network Meta-Analysis. Advances in Therapy.